Amagasaki T, Green R, Jacobsen D W
Department of Laboratory Hematology, Cleveland Clinic Foundation, OH 44195-5139.
Blood. 1990 Oct 1;76(7):1380-6.
Plasma membrane receptors for the serum cobalamin-binding protein transcobalamin II (TCII) were identified on human leukemia K562 and HL-60 cells using immunoaffinity-purified human TCII labeled with [57Co]cyanocobalamin. The Bmax values for TCII receptors on proliferating K562 and HL-60 cells were 4,500 and 2,700 per cell, respectively. Corresponding dissociation constants (kd) were 8.0 x 10(-11) mol/L and 9.0 x 10(-11) mol/L. Rabbit TCII also bound to K562 and HL-60 cells but with slightly reduced affinities. Calcium was required for the binding of transcobalamin II to K562 cells. Brief treatment of these cells with trypsin resulted in almost total loss of surface binding activity. After removal of trypsin, surface receptors for TCII slowly reappeared, reaching pretrypsin treatment densities only after 24 hours. Reappearance of receptors was blocked by cycloheximide. TCII receptor densities on K562 and HL-60 cells correlated inversely with the concentration of cobalamin in the culture medium. This suggests that intracellular stores of cobalamin may affect the expression of transcobalamin receptors. Nonproliferating stationary-phase K562 cells had low TCII receptor densities (less than 1,200 receptors/cell). However, the density of TCII receptors increased substantially when cells were subcultured in fresh medium. Up-regulation of receptor expression coincided with increased 3H-thymidine incorporation, which preceded the resumption of cellular proliferation as measured by cell density. In the presence of cytosine arabinoside, which induces erythroid differentiation, K562 cells down-regulated expression of TCII receptors. When HL-60 cells were subcultured in fresh medium containing dimethysulfoxide to induce granulocytic differentiation, the up-regulation of TCII receptors was suppressed. This event occurred well before a diminution of 3H-thymidine incorporation and cessation of proliferation. Thus, changes in the regulation of expression of TCII receptors correlate with both the proliferative and differentiation status of cells.
利用用[57Co]氰钴胺标记的免疫亲和纯化的人转钴胺素II(TCII),在人白血病K562和HL-60细胞上鉴定出血清钴胺素结合蛋白转钴胺素II(TCII)的质膜受体。增殖的K562和HL-60细胞上TCII受体的Bmax值分别为每细胞4500和2700。相应的解离常数(kd)分别为8.0×10(-11)mol/L和9.0×10(-11)mol/L。兔TCII也与K562和HL-60细胞结合,但亲和力略有降低。转钴胺素II与K562细胞的结合需要钙。用胰蛋白酶短暂处理这些细胞导致表面结合活性几乎完全丧失。去除胰蛋白酶后,TCII的表面受体缓慢重新出现,仅在24小时后达到胰蛋白酶处理前的密度。受体的重新出现被环己酰亚胺阻断。K562和HL-60细胞上的TCII受体密度与培养基中钴胺素的浓度呈负相关。这表明钴胺素的细胞内储存可能影响转钴胺素受体的表达。非增殖静止期K562细胞的TCII受体密度较低(小于1200个受体/细胞)。然而,当细胞在新鲜培养基中传代培养时,TCII受体的密度显著增加。受体表达的上调与3H-胸腺嘧啶核苷掺入增加同时发生,这在通过细胞密度测量的细胞增殖恢复之前。在诱导红系分化的阿糖胞苷存在下,K562细胞下调TCII受体的表达。当HL-60细胞在含有二甲基亚砜的新鲜培养基中传代培养以诱导粒细胞分化时,TCII受体的上调被抑制。这一事件发生在3H-胸腺嘧啶核苷掺入减少和增殖停止之前很久。因此,TCII受体表达调控的变化与细胞的增殖和分化状态相关。